bell
The current prices are delayed by 15 mins, login to check live prices.
Healthcare Global Enterprises Ltd share price logo

Healthcare Global Enterprises Ltd

(HCG)

₹531.3▲2.05%

as on 04:01PM, 20 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Healthcare Global Enterprises Ltd Analyst Rating

based on 11 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 11 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹511.36

Source: S&P Global Market Intelligence

Healthcare Global Enterprises Ltd Share analysis

Healthcare Global Enterprises Ltd price forecast by 11 analysts

Downside of-5.72%

High

₹600

Target

₹511.36

Low

₹407

Healthcare Global Enterprises Ltd target price ₹511.36, a slight downside of -5.72% compared to current price of ₹531.3. According to 11 analysts rating.

Source: S&P Global Market Intelligence

Healthcare Global Enterprises Ltd Performance

  • Day's Low

    Day's High

    ₹524.85
    Day's Price Range
    ₹548

  • 52 Week's Low

    52 Week's High

    ₹314
    52-Week Price Range
    ₹548
1 Month Return+ 15.77 %
3 Month Return+ 31.43 %
1 Year Return+ 48.85 %
Previous Close₹542.40
Open₹548.00
Volume1.91L
Upper Circuit-
Lower Circuit-
Market Cap₹7,543.78Cr

Healthcare Global Enterprises Ltd Key Statistics

P/E Ratio132.29
PEG Ratio91.87
Market Cap₹7,543.78 Cr
P/B Ratio0
EPS2.97
Dividend Yield0
SectorHealthcare
ROE3.22

Healthcare Global Enterprises Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Ltd
BUY₹7,543.78 Cr87.73%0.70₹41 Cr₹1,907 Cr
Shalby Ltd
Shalby Ltd
BUY₹2,516.20 Cr26.72%0.56₹83 Cr₹933 Cr
Nephro Care India Ltd
Nephro Care India Ltd
NA₹324.53 Cr1.26%0.50NANA
Indraprastha Medical Corporation Ltd
Indraprastha Medical Corporation Ltd
NA₹4,596.79 Cr240.16%0.56NANA
Global Health Ltd
Global Health Ltd
BUY₹30,463.18 Cr34.2%0.55₹326 Cr₹2,694 Cr
See all

Healthcare Global Enterprises Ltd Mutual Fund Holdings

About Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Ltd (HCG) is a leading provider of specialty healthcare services in India, focused on cancer and fertility. With 18 comprehensive cancer centres and 7 fertility centres across India, HCG operates two multispeciality hospitals in Ahmedabad and Bhavnagar with 118 and 39 operational beds respectively, and its key specialties include cardiology, neurology, orthopaedics, and urology. It also provides clinical reference laboratory services in India under the Triesta brand specialising in oncology, and research and development services to pharmaceutical and biotechnology companies.

Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.

Share Price: ₹531.30 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹7,543.78Cr as of today
Revenue: ₹552.47Cr as on September 2024 (Q3 24)
Net Profit: ₹20.68Cr as on September 2024 (Q3 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
OrganisationHealthcare Global Enterprises Ltd
HeadquartersBengaluru
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Healthcare Global Enterprises Ltd

  • KKR's Acquisition Plans and HCG's Strong Performance - 04 Dec, 2024

    KKR is nearing a deal to acquire a 60.36% stake in Healthcare Global Enterprises (HCG) from CVC. HCG also announced a partnership with Accenture for AI-driven cancer research and reported a significant increase in net profit and revenue for Q2 FY25.

  • Healthcare Global Partners with JBG Invincible Women's Run - 14 Nov, 2024

    Healthcare Global Enterprises Limited will provide free health check-ups for participants of the JBG Invincible Women's Run with Pinkathon Mumbai 2024, enhancing community health engagement.

  • HCG Reports Strong Q2 Growth; Buy Rating Maintained - 13 Nov, 2024

    Healthcare Global Enterprises (HCG) reported a 21% YoY growth in Q2 consolidated EBITDA, reaching Rs 1.02 billion. Analysts expect further margin improvements and maintain a BUY rating with a target price of Rs 535, reflecting a 22% EBITDA CAGR over FY24-27E.

  • Healthcare Global Reports Strong Sales and Strategic Sale - 11 Nov, 2024

    Healthcare Global Enterprises Ltd reported strong financial results for September 2024, with standalone and consolidated net sales increasing significantly. The company also plans to sell its Triesta diagnostic business for Rs 135 crore to focus on growth opportunities.

  • Healthcare Global Enterprises Reports Growth and Acquisition - 09 Nov, 2024

    Healthcare Global Enterprises announced strong Q2 FY25 results with revenue of ₹552.47 crore and profit of ₹20.68 crore. Additionally, the company signed a BTA to acquire the oncology business from HCG NCHRI Oncology LLP for up to ₹25 crore.

Insights on Healthcare Global Enterprises Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, HCG stock has moved up by 9.3%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.73% to 8.94% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 12.08 Cr → 17.99 Cr (in ₹), with an average increase of 32.9% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.95% to 4.29% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 475.94 Cr → 564.67 Cr (in ₹), with an average increase of 5.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 207.8% return, outperforming this stock by 76.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Max Healthcare Institute Ltd has given 79.7% return, outperforming this stock by 31.8%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 71.25% to 71.23% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 13.90% to 12.83% in Sep 2024 quarter

Healthcare Global Enterprises Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹485.96Cr (-)₹468.95Cr (↓3.50%)₹493.25Cr (↑5.18%)₹524.69Cr (↑6.37%)₹552.47Cr (↑5.29%)
Net Income₹10.78Cr (-)₹3.43Cr (↓68.18%)₹23.46Cr (↑583.97%)₹13.63Cr (↓41.90%)₹20.68Cr (↑51.72%)
Net Profit Margin2.22% (-)0.73% (↓67.12%)4.76% (↑552.05%)2.60% (↓45.38%)3.74% (↑43.85%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,655.87Cr (-)₹1,722.91Cr (↑4.05%)₹1,815.94Cr (↑5.40%)₹2,297.46Cr (↑26.52%)
Total Liabilities₹732.08Cr (-)₹625.22Cr (↓14.60%)₹670.81Cr (↑7.29%)₹1,108.87Cr (↑65.30%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow- (-)- (-)- (-)- (-)- (-)

Index Inclusions

BSE Healthcare

₹44,095.46

-1.13 (▲-505.02%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

BSE Small-Cap

₹55,149.22

-2.11 (▲-1188.47%)

Healthcare Global Enterprises Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
71.23%
-0.03
Foreign Institutions
4.29%
8.63
Mutual Funds
8.94%
2.44
Retail Investors
12.83%
-7.72
Others
2.7%
24.92

Healthcare Global Enterprises Ltd Key Indicators

Details202220232024
Return On Equity %1.193.073.22
Details20202021202220232024
Return On Assets %-5.8-11.683.121.622.1
Details20202021202220232024
Book Value Per Share (₹)42.9952.1162.6161.8659.28
Details20202021202220232024
Earning Per Share (₹)-14.14-17.642.81.272.97

Healthcare Global Enterprises Ltd Valuation

Healthcare Global Enterprises Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-514.24x)

November 27, 2018

Industry (105.00x)

December 19, 2024

Today (132.29x)

December 19, 2024

Highest (201.31x)

July 2, 2018

LowHigh

Healthcare Global Enterprises Ltd Earnings and Dividends

  • Healthcare Global Enterprises Ltd Earnings Results

    Healthcare Global Enterprises Ltd’s net profit jumped 32.57% since last year same period to ₹17.99Cr in the Q2 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated 48.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

Healthcare Global Enterprises Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Healthcare Global Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Healthcare Global Enterprises Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Healthcare Global Enterprises Ltd shares.

Healthcare Global Enterprises Ltd (HCG) share price today is ₹531.3

Healthcare Global Enterprises Ltd is listed on NSE

Healthcare Global Enterprises Ltd is listed on BSE

  • Today’s highest price of Healthcare Global Enterprises Ltd is ₹548.
  • Today’s lowest price of Healthcare Global Enterprises Ltd is ₹524.85.

PE Ratio of Healthcare Global Enterprises Ltd is 132.29

PE ratio = Healthcare Global Enterprises Ltd Market price per share / Healthcare Global Enterprises Ltd Earnings per share

Today’s traded volume of Healthcare Global Enterprises Ltd(HCG) is 1.91L.

Today’s market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹7543.78Cr.

Healthcare Global Enterprises Ltd(HCGPrice
52 Week High
₹548
52 Week Low
₹314

Healthcare Global Enterprises Ltd(HCG) share price is ₹531.3. It is down -3.05% from its 52 Week High price of ₹548

Healthcare Global Enterprises Ltd(HCG) share price is ₹531.3. It is up 69.20% from its 52 Week Low price of ₹314

Healthcare Global Enterprises Ltd(HCGReturns
1 Day Returns
-11.1%
1 Month Returns
15.77%
3 Month Returns
31.43%
1 Year Returns
48.85%